Welcome to
Compass HealthAI

Helping restore hope and quality of life to patients suffering from central vision loss.

Our platform of ophthalmic technologies is designed to enhance the continuum of care in Age-related Macular Degeneration.

Together with our customers, we are driven to make vision better

We are committed to innovation, quality and safety.

We are dedicated to advancing the standard of care in central vision loss.

We deliver Eye Care Practitioners with the trusted tools to enhance quality of life.

Professional Testimonials of our lead-off technology: RestoRx(TM) Corneal laser

Raymond Stein, MD, FRCSC

“The treatment is easy for patients to undergo and the safety profile is superior to any other surgical treatment in ophthalmology.” “There is no downside to this superficial corneal treatment.” “such a benign treatment”.

Medical Director, Bochner Eye Institute & Innovation Centre; Professor of Ophthalmology and Vision Sciences, University of Toronto; Internationally recognized expert on corneal, refractive and cataract surgery with over 30 years of experience in performing over 100,000 successful eye surgeries; former President, Canadian Society of Cataract and Refractive Surgery.

Robert G. Devenyi, MD, FRCSC, FASRS, FACS

“We’ve experienced a spectrum of promising results and believe we are on route to being able to offer eligible patients a very safe and reliable addition to their standard of care.”

Vitreoretinal Surgeon, The Donald K. Johnson Eye Institute, The University Health Network. Professor of Ophthalmology and Vision Sciences, The University of Toronto.

Emrullah Tasindi, MD

“This procedure is much safer than any other corneal procedure such as corneal incision for cataract surgery and corneal flap generation for LASIK that is routinely performed by corneal, refractive and cataract surgeons”.

Chairman and Professor of Ophthalmology, Okan University; internationally recognized expert on corneal, refractive and cataract surgery; former Director, European Society of Cataract and Refractive Surgery; Principal Investigator – *RestoRx(TM)® Clinical Study for Vision Improvement for Patients with A

David Sliney, PhD

“it seems clear that the procedure is NSR(Non-Significant Risk) for AMD patients (with vision loss)”
Internationally recognized expert on laser/ocular safety, consultant to FDA and regulatory organizations; Author:(Sliney, D.H., Trokel, S.L.(1993). Introduction to Medical Laser Systems. In: Medical Lasers and Their Safe Use. Springer, New York, NY.)